The Ensign (ENSG) has disclosed a new risk, in the Regulation category.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
The Centers for Medicare & Medicaid Services (CMS)’s revisions to the Special Focus Facility (SFF) program, particularly the implementation of a three-year look-back period, significantly heighten operational risks for The Ensign’s subsidiaries. The modifications aim to curb the “yo-yo” pattern of noncompliance among Skilled Nursing Facilities (SNFs), but they also mean that recent SFF program graduates remain under stringent oversight. Any substantial compliance failure detected by a state survey agency during this period could lead CMS to exercise its discretion in enforcing severe sanctions, including terminating the facility’s participation in Medicare and Medicaid. This threat looms large over The Ensign, as any such punitive action would jeopardize the sustainability of their facilities and, by extension, their financial health.
Overall, Wall Street has a Moderate Buy consensus rating on ENSG stock based on 2 Buys and 1 Hold.
To learn more about The Ensign’s risk factors, click here.
